| |
| Active Pharmaceutical Ingredients |
|
| FL-3087084
Alfacalcidol, EP |
[41294-56-8]
(1α,3β,5Z,7E)-9, 10-
Secocholesta-5,7,10 (19)-
triene-1,3-diol
C27H44O2
FW 400.6
Use: Calcium regulator
Specification
|
 |
|
|
| FL-3089253
Apraclonidine hydrochloride |
[73218-79-8]
2-[(4-Amino-2,6-dichlorophenyl)imino]imidazo-
lidine monohydrochloride, USP grade
C9H10Cl2N4O
. HCl
FW 281.57
Use: Adrenergic α2-agonist
Specification
|
 |
|
|
| FL-3087049
Balsalazide Disodium Dihydrate |
[150399-21-6]
(E)-5-[[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]azo]-
2-hydroxybenzoic acid, disodium salt, dihydrate
C17H13N3Na2O6
. 2H2O
FW 437.31
Use: Agent against ulcerative colitis
Specification
|
 |
|
|
| FL-3092411
Benzonatate, USP |
[104-31-4]
Benzoic acid , 4-(butylamino)-,2,5,8,11,14,17,20,23,26-nonaoxaoctacos-28-yl
ester 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl p
-(butylamino)-benzoate
C30H53NO11
FW:603.00
Use: Symptomatic relief of cough
Specification
|
 |
|
|
| FL-3087073
Calcitriol, EP |
[32222-06-3]
(1α,3β,5Z,7E)-9, 10-Secocholesta-
5, 7, 10 (19)-triene-1, 3, 25-triol
C27H44O3
FW 416.65
Use: Calcium regulator, Anti-psoriatic
Specification
|
 |
|
|
| FL-3091321
Calcipotriol, EP |
[112965-21-6] /
[112828-00-9]
24-cyclopropyl-(1α,3β,5Z,7E,22E,24S)- 9, 10-Secochola-5,
7, 10 (19), 22-tetraene-
1, 3, 24-triol; Calcipotriene
C27H40O3
FW 412.62
Use: Anti-psoriatic
Specification |
 |
|
|
| FL-3087051
Capsaicin, USP |
| [404-86-4]
(E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
C18H27NO3
FW 305.42
Use: Topical analgesic (for neuralgia)
Specification
|
 |
|
|
| FL-3091376
Colestipol HCI |
|
[37296-80-3]
a copolymer of diethylenetramine and
1-chloro-2,3-epoxypropane with approximately one out of
five amino nitrogens protonated
Use: Cholesterol-lowering agent
Specification
|
|
|
|
| FL-3087051 Doxercalciferol |
[54573-75-0]
Use: For the treatment of secondary hyperparathyroidism
|  |
|
| FL-3087027
Fludiazepam |
[3900-31-0]
7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-
1-methyl-2H-1,4-benzodiazepin-2-one,
JP grade
C16H12ClFN2O
FW 302.7
Use: Anxiolytic, Sedative
Specification
|
 |
|
|
| FL-3091332
Flupentixol dihydrochloride, BP |
[2413-38-9]
2-[4-[3-(E,Z)-2-(trifluoromethyl)-9H-
thioxanthen-9-ylidene]propyl]piperazin-
1-yl]-ethanol dihydrochloride
C23H27Cl2F3N2OS
. 2HCl
FW 507.4
Use: Antipsychotic
Specification
|
 |
|
|
| FL-3093477 Flupentixol
decanoate |
[30909-51-4]
Use: Antipsychotic
Specification |
 |
|
|
| FL-3095545 Gadodiamide , USP |
[122795-43-1] |
Use: MRI enhancing agent
|
|
 |
|
|
| FL-3087038
Leflunomide |
[75706-12-6]
α,α,α-Trifluoro-5-methyl-4-
isoxazolecarboxy-p-toluidide,
C12H9F3N2O2
FW 270.21
Use: Disease-modifying anti-rheumatic drug
Specification
|
 |
|
|
|
| FL-3091343
Melitracen hydrochloride |
[10563-70-9]
3-(10,10-Dimethyl-9(10H)-anthracenylidene)-
N, N-dimethyl-1-propanamine hydrochloride
C21H25N
. HCl
FW 327.89
Use: Antipsychotic
Specification
|
 |
| FL-3091365
Mifepristone |
[84371-65-3]
(11ß,17ß)-11-[4-(Dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)
estra-4,9-dien-3-one
C29H35NO2
FW:429.60
Use: Abortifacient
Specification
|
 |
| FL-3093501 Montelukast Sodium |
[15 1767-02-1 ]
Use: Anti-asthmatic
|
 |
|
| FL-3091398
Mycophenolate Mofetil |
[128794-94-5]
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,
2-(4-morpholinyl)ethyl ester
C23H31NO7
FW 433.49
Use: Immunosuppressant
Specification
|
 |
|
|
| FL-3088174
Nonivamide |
[2444-46-4]
N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-nonanamide, >98%
C17H27NO3
FW 293.40
Use: Rodent or insect repellent, Lacrimator, Food seasoning
Specification
|
 |
|
| Propiverine Hydrochloride |
[54556-98-8]
Use: : Anticholinergic or antimuscarinic muscle relaxant
|
 |
|
| |
|
Notice: Please be reminded that some products listed above are
still patented and can only be made available for R & D
use as permitted under 35 USC 271 (e) (1). We will not be responsible
if the use of any of the above products infringes on any patent
in your country. |
| |
| Intermediates |
|
FL-3087106
5-Methylisoxazole-4-carboxylic acid |
[42831-50-5]
C5H5NO3
FW 113.09
Use: Intermediate for leflunomide
Specification
|
 |
|
|
FL-8088029
TMBI |
[41532-84-7]
C15H15N
FW 209.30
Use: Intermediate for cyanine dyes
Specification
|
 |
|
|
FL-3087117
N-Vanillylamine Hydrochloride |
[7149-10-2]
C8H11O2
. HCl
FW 175.5
Use: Intermediate for Capsaicin
and N-Vanillylnonanamide
Specification
|
 |
|
| |
|
|
|